UN Global Dialogue On Innovation And Access To Medicines This Week 08/03/2016 by Intellectual Property Watch Leave a Comment The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.
WHO: Zika Virus Spreading, R&D Needs Financing, Sample Sharing Discussed 08/03/2016 by Catherine Saez, Intellectual Property Watch 5 Comments The World Health Organization said today that evidence of the relationship between the Zika virus and neonatal malformations and neurological disorders is growing stronger. The Emergency Committee set up by the WHO at a gathering today issued advice to the WHO director general, including warning pregnant women to avoid travelling to Zika infected countries. Meanwhile, discussions are ongoing on the sharing of the samples of the virus, and on the question of benefit-sharing. And a call was made for research and development to intensify.
WHO To Hold Stakeholder Consultation On Status Of Zika Research Next Week 04/03/2016 by Intellectual Property Watch 1 Comment The World Health Organization has announced it will hold a closed-door, three-day consultation with key stakeholders next week in Geneva to discuss the current status of clinical research into the Zika virus.
Alleged R&D Costs: Not A Transparent Driver Of Drug Prices 04/03/2016 by Intellectual Property Watch 3 Comments Whether laws enforcing transparency on costs would help curb extortionate drug prices in today’s world is hardly predictable now that pharma companies and their allies are lobbying governments to scupper any rules that would require them to disclose the real R&D costs and profits of their medicines and the rationale for charging what they do, writes Daniele Dionisio.
Uganda In Clinical Trials For Ebola Vaccine 02/03/2016 by Hillary Muheebwa for Intellectual Property Watch 1 Comment KAMPALA, Uganda — An Ebola vaccine trial is underway in Uganda, as the global search for an effective vaccine continues. The vaccine candidate was co-developed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), and GlaxoSmithKline (GSK), a United Kingdom-based pharmaceutical company.
East Africa Pharma Summit Examines Linkages Between Domestic Policies, Industry, Trade And Health 29/02/2016 by Fredrick Nzwili for Intellectual Property Watch Leave a Comment NAIROBI, Kenya — As the budding East African pharmaceutical industry shows clear gains , experts at a pharmaceutical summit in Kenya underlined the sector as key to tackling challenges related to access to essential medicines in the region.
UNITAID Report On Delinking R&D Costs From Medicines Prices 28/02/2016 by Intellectual Property Watch Leave a Comment Delinkage of research and development costs from medicines prices could “vastly expand” access to medicines by drastically dropping costs of the knowledge component of health products, innovative medicines R&D facility UNITAID says in a new report.
UAEM’s Re:Route – New Mapping Tool For Alternative Health R&D Models 25/02/2016 by Priti Patnaik for Intellectual Property Watch Leave a Comment Re:Route, a mapping tool that lays out the research and development (R&D) landscape of innovation and financing for medicines, has been launched by the Universities Allied for Essential Medicines (UAEM). It is a one-stop place for the alternative biomedical research and development landscape.
EU Parliament Members Seek To Curb Antibiotics In Animals, Boost New Research 18/02/2016 by Intellectual Property Watch 1 Comment In the fight against antimicrobial resistance, members of the European Parliament’s Environment and Public Health Committee have advocated banning collective and preventive antibiotic treatment of animals, and supported measures to stimulate research into new antibiotics, including longer data protection.
WHO Issues Strategy For Zika Global Response; US$56 Million Needed 17/02/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization today issued its strategic response framework and joint operations and research plan, which lays out a strategy until June, to investigate and respond to the medical complications linked to the spreading Zika virus.